127 related articles for article (PubMed ID: 30214243)
1. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
Gao F; Yu X; Meng R; Wang J; Jia L
Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
[TBL] [Abstract][Full Text] [Related]
2. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
3. Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells.
Chen K; Wei H; Pan J; Chen Z; Pan D; Gao T; Huang J; Huang M; Ou M; Zhong W
Eur J Pharmacol; 2019 Oct; 861():172599. PubMed ID: 31404537
[TBL] [Abstract][Full Text] [Related]
4. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Biomed Pharmacother; 2018 Aug; 104():204-210. PubMed ID: 29772441
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis.
Li X; Jia Q; Zhou Y; Jiang X; Song L; Wu Y; Wang A; Chen W; Wang S; Lu Y
Exp Hematol Oncol; 2022 Jan; 11(1):2. PubMed ID: 35057866
[TBL] [Abstract][Full Text] [Related]
6. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Gao L; Cheng XL; Cao H
Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.
Hu R; Zhu X; Chen C; Xu R; Li Y; Xu W
Cell Prolif; 2018 Dec; 51(6):e12508. PubMed ID: 30084199
[TBL] [Abstract][Full Text] [Related]
8. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
[No Abstract] [Full Text] [Related]
10. STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas.
Zhang H; Wang F; Hu Y
Biotechnol Lett; 2017 Feb; 39(2):207-217. PubMed ID: 27844181
[TBL] [Abstract][Full Text] [Related]
11. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.
Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J
Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062
[TBL] [Abstract][Full Text] [Related]
12. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.
Qin J; Shi H; Xu Y; Zhao F; Wang Q
Biomed Pharmacother; 2018 Sep; 105():758-765. PubMed ID: 29909343
[TBL] [Abstract][Full Text] [Related]
14. Dichloroacetate attenuates the stemness of hepatocellular carcinoma cells via promoting nucleus-cytoplasm translocation of YAP.
Su D; Lin Z
Environ Toxicol; 2021 May; 36(5):975-983. PubMed ID: 33405312
[TBL] [Abstract][Full Text] [Related]
15. MiR-490-5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2.
Yu Y; Cai O; Wu P; Tan S
J Cell Biochem; 2019 Jan; 120(1):967-976. PubMed ID: 30206962
[TBL] [Abstract][Full Text] [Related]
16. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
[TBL] [Abstract][Full Text] [Related]
17. CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity.
Fu Y; Ci H; Du W; Dong Q; Jia H
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214008
[TBL] [Abstract][Full Text] [Related]
18. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
[TBL] [Abstract][Full Text] [Related]
19. E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes.
Fu Y; Hu C; Du P; Huang G
J Oncol; 2021; 2021():6611327. PubMed ID: 33986804
[TBL] [Abstract][Full Text] [Related]
20. High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells.
Cao H; Chu X; Wang Z; Guo C; Shao S; Xiao J; Zheng J; Zhang D
Life Sci; 2019 Jul; 228():128-134. PubMed ID: 31054270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
